Does USTEKINUMAB Cause Product packaging issue? 221 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Product packaging issue have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.3% of all adverse event reports for USTEKINUMAB.
221
Reports of Product packaging issue with USTEKINUMAB
0.3%
of all USTEKINUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product packaging issue From USTEKINUMAB?
Of the 221 reports, 3 (1.4%) required hospitalization.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 221 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
RIVAROXABAN (93)
Which USTEKINUMAB Alternatives Have Lower Product packaging issue Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE